Therapeutic recommendations in HFE hemochromatosis for p.Cys282Tyr (C282Y/C282Y) homozygous genotype
dc.contributor | Sistema FMUSP-HC: Faculdade de Medicina da Universidade de São Paulo (FMUSP) e Hospital das Clínicas da FMUSP | |
dc.contributor.author | ADAMS, Paul | |
dc.contributor.author | ALTES, Albert | |
dc.contributor.author | BRISSOT, Pierre | |
dc.contributor.author | BUTZECK, Barbara | |
dc.contributor.author | CABANTCHIK, Ioav | |
dc.contributor.author | CANCADO, Rodolfo | |
dc.contributor.author | DISTANTE, Sonia | |
dc.contributor.author | EVANS, Patricia | |
dc.contributor.author | EVANS, Robert | |
dc.contributor.author | GANZ, Tomas | |
dc.contributor.author | GIRELLI, Domenico | |
dc.contributor.author | HULTCRANTZ, Rolf | |
dc.contributor.author | MCLAREN, Gordon | |
dc.contributor.author | MARRIS, Ben | |
dc.contributor.author | MILMAN, Nils | |
dc.contributor.author | NEMETH, Elizabeta | |
dc.contributor.author | NIELSEN, Peter | |
dc.contributor.author | PINEAU, Brigitte | |
dc.contributor.author | PIPERNO, Alberto | |
dc.contributor.author | PORTO, Graca | |
dc.contributor.author | PRINCE, Dianne | |
dc.contributor.author | RYAN, John | |
dc.contributor.author | SANCHEZ, Mayka | |
dc.contributor.author | SANTOS, Paulo | |
dc.contributor.author | SWINKELS, Dorine | |
dc.contributor.author | TEIXEIRA, Emerencia | |
dc.contributor.author | TOSKA, Ketil | |
dc.contributor.author | VANCLOOSTER, Annick | |
dc.contributor.author | WHITE, Desley | |
dc.contributor.groupauthor | Contributors Hemochromatosis Int | |
dc.date.accessioned | 2018-07-05T18:06:46Z | |
dc.date.available | 2018-07-05T18:06:46Z | |
dc.date.issued | 2018 | |
dc.description.abstract | Although guidelines are available for hereditary hemochromatosis, a high percentage of the recommendations within them are not shared between the different guidelines. Our main aim is to provide an objective, simple, brief, and practical set of recommendations about therapeutic aspects of HFE hemochromatosis for p. Cys282Tyr (C282Y/C282Y) homozygous genotype, based on the published scientific studies and guidelines, in a form that is reasonably comprehensible to patients and people without medical training. This final version was approved at the Hemochromatosis International meeting on 12th May 2017 in Los Angeles. | |
dc.description.index | MEDLINE | |
dc.description.sponsorship | La Jolla | |
dc.description.sponsorship | Novartis | |
dc.identifier.citation | HEPATOLOGY INTERNATIONAL, v.12, n.2, p.83-86, 2018 | |
dc.identifier.doi | 10.1007/s12072-018-9855-0 | |
dc.identifier.eissn | 1936-0541 | |
dc.identifier.issn | 1936-0533 | |
dc.identifier.uri | https://observatorio.fm.usp.br/handle/OPI/27076 | |
dc.language.iso | eng | |
dc.publisher | SPRINGER | |
dc.relation.ispartof | Hepatology International | |
dc.rights | restrictedAccess | |
dc.rights.holder | Copyright SPRINGER | |
dc.subject.other | diagnosis | |
dc.subject.other | diseases | |
dc.subject.wos | Gastroenterology & Hepatology | |
dc.title | Therapeutic recommendations in HFE hemochromatosis for p.Cys282Tyr (C282Y/C282Y) homozygous genotype | |
dc.type | article | |
dc.type.category | original article | |
dc.type.version | publishedVersion | |
dspace.entity.type | Publication | |
hcfmusp.affiliation.country | Inglaterra | |
hcfmusp.affiliation.country | Canadá | |
hcfmusp.affiliation.country | Espanha | |
hcfmusp.affiliation.country | Alemanha | |
hcfmusp.affiliation.country | Israel | |
hcfmusp.affiliation.country | Noruega | |
hcfmusp.affiliation.country | França | |
hcfmusp.affiliation.country | Estados Unidos | |
hcfmusp.affiliation.country | Itália | |
hcfmusp.affiliation.country | Suécia | |
hcfmusp.affiliation.country | Austrália | |
hcfmusp.affiliation.country | Dinamarca | |
hcfmusp.affiliation.country | Portugal | |
hcfmusp.affiliation.country | Holanda | |
hcfmusp.affiliation.country | Bélgica | |
hcfmusp.affiliation.countryiso | ca | |
hcfmusp.affiliation.countryiso | es | |
hcfmusp.affiliation.countryiso | gb | |
hcfmusp.affiliation.countryiso | de | |
hcfmusp.affiliation.countryiso | il | |
hcfmusp.affiliation.countryiso | no | |
hcfmusp.affiliation.countryiso | fr | |
hcfmusp.affiliation.countryiso | us | |
hcfmusp.affiliation.countryiso | it | |
hcfmusp.affiliation.countryiso | se | |
hcfmusp.affiliation.countryiso | au | |
hcfmusp.affiliation.countryiso | dk | |
hcfmusp.affiliation.countryiso | pt | |
hcfmusp.affiliation.countryiso | nl | |
hcfmusp.affiliation.countryiso | be | |
hcfmusp.author.external | ADAMS, Paul:Western Univ, Univ Hosp, London, ON, Canada | |
hcfmusp.author.external | ALTES, Albert:Asociac Espanola Hemocromatosis, Santa Coloma, Spain | |
hcfmusp.author.external | BRISSOT, Pierre:Univ Hosp Pontchaillou, INSERM, Unit 1241, Rennes, France; Haemochromatosis Int, London, England | |
hcfmusp.author.external | BUTZECK, Barbara:Haemochromatosis Int, London, England; European Federat Assoc Patients Haemochromatosis, Seine, France; Haemochromatose Vereinigung Deutschland, Hurth, Germany | |
hcfmusp.author.external | CABANTCHIK, Ioav:Int Bioiron Soc, Schaumburg, IL USA; Hebrew Univ Jerusalem, Jerusalem, Israel | |
hcfmusp.author.external | CANCADO, Rodolfo:Santa Casa Med Sch Sao Paulo, Div Hematol, Sao Paulo, SP, Brazil | |
hcfmusp.author.external | DISTANTE, Sonia:Oslo Univ Hosp, Dept Med Biochem, Oslo, Norway | |
hcfmusp.author.external | EVANS, Patricia:Haemochromatosis Int, London, England; European Federat Assoc Patients Haemochromatosis, Seine, France | |
hcfmusp.author.external | EVANS, Robert:Haemochromatosis Int, London, England; Brunel Univ, Sch Engn & Design, Dept Elect & Comp Engn, Uxbridge, Middx, England; Haemochromatosis Soc, Barnet, Herts, England | |
hcfmusp.author.external | GANZ, Tomas:Univ Calif Los Angeles, David Geffen Sch Med, Los Angeles, CA 90095 USA | |
hcfmusp.author.external | GIRELLI, Domenico:Univ Verona, Dept Med, Veneto Reg Referral Ctr Iron Metab Disorders, Verona, Italy | |
hcfmusp.author.external | HULTCRANTZ, Rolf:Karolinska Inst, Dept Med, Unit Gastroenterol & Rheumatol, Stockholm, Sweden | |
hcfmusp.author.external | MCLAREN, Gordon:Univ Calif Irvine, Div Hematol Oncol, Irvine, CA USA | |
hcfmusp.author.external | MARRIS, Ben:Haemochromatosis Int, London, England; Haemochromatosis Australia, Meridan Plains, Australia | |
hcfmusp.author.external | MILMAN, Nils:Danish Haemochromatosis Assoc, Copenhagen, Denmark | |
hcfmusp.author.external | NEMETH, Elizabeta:Univ Calif Los Angeles, David Geffen Sch Med, Ctr Iron Disorders, Los Angeles, CA 90095 USA | |
hcfmusp.author.external | NIELSEN, Peter:Univ Med Ctr Hamburg, Inst Biochem & Mol Zellbiol, Hamburg, Germany | |
hcfmusp.author.external | PINEAU, Brigitte:Federat Francaise Assoc Malad Hemochromatose, Paris, France | |
hcfmusp.author.external | PIPERNO, Alberto:Univ Milano Bicocca, Dept Med & Surg, Ctr Rare Dis, Monza, Italy; Assoc Study Hemochromatosis & Iron Overload Dis, Monza, Italy | |
hcfmusp.author.external | PORTO, Graca:Univ Porto, Inst Biol Mol & Celular, Porto, Portugal; Univ Porto, Inst Invest & Inovacao Saude, Porto, Portugal; Hosp Santo Antonio, Ctr Hosp Porto, Porto, Portugal | |
hcfmusp.author.external | PRINCE, Dianne:Haemochromatosis Int, London, England; Haemochromatosis Australia, Meridan Plains, Australia | |
hcfmusp.author.external | RYAN, John:Oxford Univ Hosp NHS Fdn Trust, John Radcliffe Hosp, Oxford, England | |
hcfmusp.author.external | SANCHEZ, Mayka:Asociac Espanola Hemocromatosis, Santa Coloma, Spain | |
hcfmusp.author.external | SWINKELS, Dorine:Radboudumc, Dept Lab Med, Nijmegen, Netherlands | |
hcfmusp.author.external | TEIXEIRA, Emerencia:Haemochromatosis Int, London, England; Univ Porto, Inst Biol Mol & Celular, Porto, Portugal; Univ Porto, Inst Invest & Inovacao Saude, Porto, Portugal; Univ Porto, Fac Ciencias, Porto, Portugal; Assoc Portuguesa Hemocromatose, Porto, Portugal | |
hcfmusp.author.external | TOSKA, Ketil:Haemochromatosis Int, London, England; Norwegian Haemochromatosis Assoc, Bergen, Norway | |
hcfmusp.author.external | VANCLOOSTER, Annick:Univ Hosp Leuven, Louvain, Belgium; Haemochromatose Vereniging Vlaanderen, Leuven, Belgium | |
hcfmusp.author.external | WHITE, Desley:Haemochromatosis Int, London, England; Univ Plymouth, Plymouth, Devon, England | |
hcfmusp.citation.scopus | 39 | |
hcfmusp.contributor.author-fmusphc | PAULO CALEB JUNIOR DE LIMA SANTOS | |
hcfmusp.description.beginpage | 83 | |
hcfmusp.description.endpage | 86 | |
hcfmusp.description.issue | 2 | |
hcfmusp.description.volume | 12 | |
hcfmusp.origem | WOS | |
hcfmusp.origem.pubmed | 29589198 | |
hcfmusp.origem.scopus | 2-s2.0-85044480865 | |
hcfmusp.origem.wos | WOS:000430317500001 | |
hcfmusp.publisher.city | NEW YORK | |
hcfmusp.publisher.country | USA | |
hcfmusp.relation.reference | Bacon BR, 2011, HEPATOLOGY, V54, P328, DOI 10.1002/hep.24330 | |
hcfmusp.relation.reference | Bardou-Jacquet E, 2015, J HEPATOL, V62, P682, DOI 10.1016/j.jhep.2014.10.025 | |
hcfmusp.relation.reference | Brissot P, 2016, EXPERT REV GASTROENT, V10, P359, DOI 10.1586/17474124.2016.1119043 | |
hcfmusp.relation.reference | De Buck E, 2012, J HEPATOL, V57, P1126, DOI 10.1016/j.jhep.2012.04.040 | |
hcfmusp.relation.reference | Liu J, 2016, MEDICINE, V95, DOI 10.1097/MD.0000000000003150 | |
hcfmusp.relation.reference | NIEDERAU C, 1985, NEW ENGL J MED, V313, P1256, DOI 10.1056/NEJM198511143132004 | |
hcfmusp.relation.reference | Ong SY, 2017, LANCET HAEMATOL, V4, pE607, DOI 10.1016/S2352-3026(17)30214-4 | |
hcfmusp.relation.reference | Pietrangelo A, 2010, J HEPATOL, V53, P3 | |
hcfmusp.relation.reference | Vanclooster A, 2015, CLIN RES HEPATOL GAS, V39, P205, DOI 10.1016/j.clinre.2014.09.001 | |
hcfmusp.scopus.lastupdate | 2024-05-11 | |
relation.isAuthorOfPublication | c78fbf09-2a91-499f-862e-74830b3b5fab | |
relation.isAuthorOfPublication.latestForDiscovery | c78fbf09-2a91-499f-862e-74830b3b5fab |
Arquivos
Pacote Original
1 - 1 de 1
Nenhuma Miniatura disponível
- Nome:
- art_ADAMS_Therapeutic_recommendations_in_HFE_hemochromatosis_for_pCys282Tyr_C282YC282Y_2018.PDF
- Tamanho:
- 332.53 KB
- Formato:
- Adobe Portable Document Format
- Descrição:
- publishedVersion (English)